{{Chembox
| ImageFile = Flopristin.svg
| ImageSize = 200px
| ImageAlt =
| IUPACName =
| OtherNames = (16''R'')-16-Desoxy-16-fluoropristinamycin IIB; RPR 132552; RPR 132552A
|Section1={{Chembox Identifiers
| CASNo = 318498-76-9
| CASNo_Ref = {{cascite|correct|}}
| UNII = OZV2QPB39M
| PubChem =
| SMILES = O[C@H](/C=C(C)/C=C/CNC(/C=C/[C@@H](C)[C@H](OC1=O)C(C)C)=O)C[C@@H](F)CC2=NC(C(N3[C@@H]1CCC3)=O)=CO2}}
|Section2={{Chembox Properties
| C=28 | H=38 | F=1 | N=3 | O=6
| Appearance =
| Density =
| MeltingPt =
| BoilingPt =
| Solubility = }}
|Section3={{Chembox Hazards
| MainHazards =
| FlashPt =
| AutoignitionPt = }}
}}

'''Flopristin''' is a [[semisynthesis|semi-synthetic]] [[antibiotic]] of the [[streptogramin A]] class.  It is a [[fluorination|fluorinated]] [[derivative (chemistry)|derivative]] of [[pristinamycin IIB]].

Flopristin is one of the components of the experimental drug [[NXL103]].<ref>{{cite journal |author1=Pankuch, Glenn A. |author2=Kelly, Linda M. |author3=Lin, Gengrong |author4=Bryskier, Andre |author5=Couturier, Catherine |author6=Jacobs, Michael R. |author7=Appelbaum, Peter C. | title = Activities of a new oral streptogramin, XRP 2868, compared to those of other agents against Streptococcus pneumoniae and Haemophilus species | journal = Antimicrobial Agents and Chemotherapy | year = 2003 | volume = 47 | issue = 10 | pages = 3270â€“3274 | doi = 10.1128/AAC.47.10.3270-3274.2003 | pmid = 14506040 | pmc = 201162}}</ref>

==References==
{{reflist}}

[[Category:Macrolide antibiotics]]
[[Category:Oxazoles]]
[[Category:Organofluorides]]


{{antibiotic-stub}}